GlassScriptPhysician profile
Scott N Surasky
NPI 1265527105
$1,714.59
in general payments reported to CMS, 2019-2025
17 companies · $143 in 2025
The $143 reported for 2025 was more than what 81% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $363 · 2021: $528 · 2022: $412 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $201.07 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $193.37 | 2020-2022 | |
| Abbott Laboratories | $147.06 | 2021 | |
| Djo, LLC | $142.69 | 2025 | Cmf |
| Amgen INC. | $125.00 | 2019 | |
| Redhill Biopharma INC. | $123.23 | 2020-2022 | |
| Relievant Medsystems, INC. | $122.62 | 2022 | |
| Xtant Medical INC | $120.00 | 2022 | |
| Surgalign Spine Technologies, INC. | $115.34 | 2021 | |
| Supernus Pharmaceuticals, INC. | $111.87 | 2021-2022 | |
| Depuy Synthes Sales INC. | $85.75 | 2020 | |
| Lundbeck LLC | $57.22 | 2020 | |
| Orexo US, INC. | $50.69 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $47.17 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $35.01 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $21.81 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Surasky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.